Form 4 for SPRY ARS Pharmaceuticals, Inc.
Accepted 2024-11-21 00:00:00 ET · period of report 2024-11-19 · accession 0001415889-24-027410 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-11-21 | 2024-11-19 | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $13.95 | -100.0K | 1.35M | -7% | -$1.40M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-19 | S | D | 50,000 | $13.95 | 1,198,499 | I By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006 | — | — | (F1) The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023. (F4) The weighted average sale price for the transaction reported was $13.949,and the range of prices were between $13.50 and $14.28. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. (F5) The shares are held in trust for the benefit of the Reporting Person and her spouse. The Reporting Person and her spouse are trustees of the trust. |
| 2 | Common | Common Stock | 2024-11-19 | S | D | 50,000 | $13.95 | 1,347,447 | I By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020 | — | — | (F1) The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023. (F2) The weighted average sale price for the transaction reported was $13.9502 and the range of prices were between $13.50 and $14.25. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. (F3) The Reporting Person is trustee of the trust. |